Quebec Reports the Intention on Implementing Shift Towards Biosimilars

 Quebec Reports the Intention on Implementing Shift Towards Biosimilars

Shots:

  • Quebec government has stated province intention to shift towards biosimilars and follows the transition policies implemented by British Columbia, Alberta & New Brunswick
  • The expanded use of biosimilars is expected to generate annual savings of $100M for the public drug insurance plan and its insured parties that can be reinvested in healthcare and innovative new drugs
  • Under the policy, the transition from reference biologic to a biosimilar will take place under the supervision of treated physicians by April 12, 2022

Click here to­ read full press release/ article | Ref: Quebac| Image: Quebec

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post